vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Hilltop Holdings Inc. (HTH). Click either name above to swap in a different company.
Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $268.1M, roughly 1.1× ACADIA PHARMACEUTICALS INC). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 1.4%, a 11.6% gap on every dollar of revenue. Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs 0.6%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.
ACAD vs HTH — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $300.5M |
| Net Profit | $3.6M | $39.0M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | — |
| Net Margin | 1.4% | 13.0% |
| Revenue YoY | 9.7% | — |
| Net Profit YoY | — | -12.4% |
| EPS (diluted) | $0.02 | $0.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $300.5M | ||
| Q4 25 | $284.0M | $329.9M | ||
| Q3 25 | $278.6M | $330.2M | ||
| Q2 25 | $264.6M | $303.3M | ||
| Q1 25 | $244.3M | $318.5M | ||
| Q4 24 | $259.6M | $301.1M | ||
| Q3 24 | $250.4M | $305.5M | ||
| Q2 24 | $242.0M | $297.0M |
| Q1 26 | $3.6M | $39.0M | ||
| Q4 25 | $273.6M | $41.6M | ||
| Q3 25 | $71.8M | $45.8M | ||
| Q2 25 | $26.7M | $36.1M | ||
| Q1 25 | $19.0M | $42.1M | ||
| Q4 24 | $143.7M | $35.5M | ||
| Q3 24 | $32.8M | $29.7M | ||
| Q2 24 | $33.4M | $20.3M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 16.1% | ||
| Q3 25 | 12.8% | 18.4% | ||
| Q2 25 | 12.2% | 16.3% | ||
| Q1 25 | 7.9% | 18.1% | ||
| Q4 24 | 59.1% | 14.7% | ||
| Q3 24 | 12.6% | 13.9% | ||
| Q2 24 | 12.6% | 10.0% |
| Q1 26 | 1.4% | 13.0% | ||
| Q4 25 | 96.3% | 12.6% | ||
| Q3 25 | 25.8% | 13.9% | ||
| Q2 25 | 10.1% | 11.9% | ||
| Q1 25 | 7.8% | 13.2% | ||
| Q4 24 | 55.4% | 11.8% | ||
| Q3 24 | 13.1% | 9.7% | ||
| Q2 24 | 13.8% | 6.8% |
| Q1 26 | $0.02 | $0.64 | ||
| Q4 25 | $1.61 | $0.68 | ||
| Q3 25 | $0.42 | $0.74 | ||
| Q2 25 | $0.16 | $0.57 | ||
| Q1 25 | $0.11 | $0.65 | ||
| Q4 24 | $0.86 | $0.55 | ||
| Q3 24 | $0.20 | $0.46 | ||
| Q2 24 | $0.20 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $990.8M |
| Stockholders' EquityBook value | — | $2.2B |
| Total Assets | $1.6B | $15.7B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | — | ||
| Q2 24 | $177.1M | — |
| Q1 26 | — | $990.8M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.2B | $2.2B | ||
| Q3 25 | $917.3M | $2.2B | ||
| Q2 25 | $822.4M | $2.2B | ||
| Q1 25 | $765.2M | $2.2B | ||
| Q4 24 | $732.8M | $2.2B | ||
| Q3 24 | $577.2M | $2.2B | ||
| Q2 24 | $516.7M | $2.1B |
| Q1 26 | $1.6B | $15.7B | ||
| Q4 25 | $1.6B | $15.8B | ||
| Q3 25 | $1.3B | $15.6B | ||
| Q2 25 | $1.2B | $15.4B | ||
| Q1 25 | $1.1B | $15.8B | ||
| Q4 24 | $1.2B | $16.3B | ||
| Q3 24 | $976.9M | $15.9B | ||
| Q2 24 | $914.1M | $15.6B |
| Q1 26 | — | 0.46× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
Segment breakdown not available.
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |
